Nasdaq-listed biotech firm Sonnet BioTherapeutics announced Monday a $888 million merger agreement with Rorschach I LLC, an ...

Sonnet BioTherapeutics enters into an agreement to transform into the largest U.S.-based publicly listed company to hold HYPE ...

Shares of Sonnet BioTherapeutics, Inc. (SONN) soared on Monday after the company entered a definitive business combination agreement with Rorschach I LLC to build a reserve of HYPE, the token of the ...

Hyperliquid (HYPE) trades near $48 on Monday following Sonnet BioTherapeutics' (SONN) announcement that it has entered a ...

Sonnet BioTherapeutics pivots to crypto with $888M deal, forming Hyperliquid Strategies Inc. to hold 12.6M HYPE tokens.

Rorschach tests play with the human imagination and our mind's ability to impart meaning onto the world around us – but what does AI see in them? For more than a century, the Rorschach inkblot ...

When AI was presented with one of the most common Rorschach inkblots—a shape often interpreted by humans as a bat, butterfly, or moth—it responded differently. At first, ...

The Rorschach test is a psychological test designed by psychiatrist Hermann Rorschach in the early 1900s. The test involves presenting a subject with images of inkblots; the person then describes ...

Rorschach, who died in 1922, is best known for creating the inkblot test — an experiment in which patients are asked to interpret a series of abstract, symmetrical shapes.